Nuvaxovid JN.1®: COVID-19 Vaccine Unavailable from May
Nuvaxovid JN.1® COVID-19 Vaccine Discontinued in Germany
Table of Contents
- Nuvaxovid JN.1® COVID-19 Vaccine Discontinued in Germany
- Nuvaxovid JN.1® COVID-19 Vaccine: Key Questions Answered
- Introduction
- Core Questions and Answers
- 1. Is the Nuvaxovid JN.1® vaccine still available?
- 2.Why was the Nuvaxovid JN.1® vaccine discontinued?
- 3.What should medical practices do with remaining doses of Nuvaxovid JN.1®?
- 4. What COVID-19 vaccines are available in Germany now?
- 5. Will the Nuvaxovid JN.1® vaccine be available for the 2025/2026 vaccination season?
- Summary Table: Nuvaxovid JN.1® Vaccine Status in Germany
Berlin — The protein-based COVID-19 vaccine Nuvaxovid JN.1® is no longer available in Germany as of May 1, 2025.
the Center for Pandemic Vaccines and Therapy Agents at the Paul-Ehrlich-Institut (Zepai) announced that all vaccine lots had reached their expiration date by April 30. The institute stated that the vaccine is not adapted to the Omicron variant.
Medical practices are advised to properly dispose of any remaining doses of the Nuvaxovid JN.1® vaccine.
The federal government will continue to provide Omicron-adapted COVID-19 vaccines from Biontech/Pfizer as an option.
Zepai reports that the future availability of the Nuvaxovid JN.1® vaccine for the 2025/2026 vaccination season remains uncertain.
Nuvaxovid JN.1® COVID-19 Vaccine: Key Questions Answered
Introduction
This article provides answers to common questions about the Nuvaxovid JN.1® COVID-19 vaccine, focusing on its status and availability.
Core Questions and Answers
1. Is the Nuvaxovid JN.1® vaccine still available?
No, the Nuvaxovid JN.1® COVID-19 vaccine is no longer available in Germany as of May 1, 2025.
2.Why was the Nuvaxovid JN.1® vaccine discontinued?
All vaccine lots of the Nuvaxovid JN.1® vaccine expired by April 30. The center for Pandemic Vaccines and Therapy Agents at the Paul-Ehrlich-Institut (Zepai) made this announcement. The institute also stated the vaccine is not adapted to the Omicron variant.
3.What should medical practices do with remaining doses of Nuvaxovid JN.1®?
Medical practices are advised to properly dispose of any remaining doses of the Nuvaxovid JN.1® vaccine.
4. What COVID-19 vaccines are available in Germany now?
The German federal government will continue to offer Omicron-adapted COVID-19 vaccines from Biontech/Pfizer.
5. Will the Nuvaxovid JN.1® vaccine be available for the 2025/2026 vaccination season?
The future availability of the Nuvaxovid JN.1® vaccine for the 2025/2026 vaccination season remains uncertain.
Summary Table: Nuvaxovid JN.1® Vaccine Status in Germany
| Aspect | Details |
|———————-|——————————————————–|
| Availability | Discontinued as of May 1, 2025 |
| Reason for Discontinuation | Expiration of vaccine lots; not adapted to Omicron |
| Official Source | Zepai (Paul-Ehrlich-Institut) |
| Alternative Vaccines | Omicron-adapted vaccines from Biontech/Pfizer |
| Future Availability | Uncertain for 2025/2026 season |